| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 27 | 2023 | 1641 | 2.710 |
Why?
|
| Hepatitis C, Chronic | 12 | 2018 | 451 | 2.060 |
Why?
|
| Liver Cirrhosis | 15 | 2018 | 941 | 1.910 |
Why?
|
| Hepatitis C | 8 | 2018 | 524 | 1.230 |
Why?
|
| Stress Disorders, Post-Traumatic | 4 | 2020 | 604 | 0.950 |
Why?
|
| HIV Infections | 12 | 2022 | 2134 | 0.870 |
Why?
|
| Carcinoma, Hepatocellular | 7 | 2018 | 2027 | 0.830 |
Why?
|
| Glaucoma, Open-Angle | 2 | 2021 | 38 | 0.810 |
Why?
|
| Liver Neoplasms | 9 | 2018 | 4557 | 0.790 |
Why?
|
| Receptor for Advanced Glycation End Products | 2 | 2018 | 38 | 0.780 |
Why?
|
| Sarcoma, Kaposi | 2 | 2019 | 187 | 0.750 |
Why?
|
| Hepacivirus | 5 | 2017 | 397 | 0.740 |
Why?
|
| Liver Diseases | 4 | 2015 | 574 | 0.720 |
Why?
|
| Papillomavirus Infections | 3 | 2023 | 980 | 0.710 |
Why?
|
| Oropharyngeal Neoplasms | 3 | 2023 | 1105 | 0.700 |
Why?
|
| alpha-Fetoproteins | 3 | 2018 | 237 | 0.680 |
Why?
|
| Gastrointestinal Microbiome | 7 | 2023 | 907 | 0.660 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2019 | 163 | 0.650 |
Why?
|
| Parkinson Disease | 2 | 2020 | 708 | 0.630 |
Why?
|
| United States Department of Veterans Affairs | 5 | 2019 | 605 | 0.620 |
Why?
|
| Adipokines | 1 | 2018 | 96 | 0.620 |
Why?
|
| Polymorphism, Genetic | 3 | 2015 | 1450 | 0.610 |
Why?
|
| Colon | 5 | 2021 | 670 | 0.590 |
Why?
|
| Algorithms | 5 | 2019 | 3890 | 0.580 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 367 | 0.510 |
Why?
|
| Fatty Liver | 2 | 2012 | 235 | 0.460 |
Why?
|
| Middle Aged | 47 | 2022 | 86204 | 0.460 |
Why?
|
| Diet | 3 | 2019 | 1440 | 0.460 |
Why?
|
| Head and Neck Neoplasms | 3 | 2023 | 3976 | 0.440 |
Why?
|
| Body Fat Distribution | 1 | 2012 | 29 | 0.440 |
Why?
|
| Irritable Bowel Syndrome | 3 | 2010 | 208 | 0.440 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2012 | 20 | 0.430 |
Why?
|
| Finasteride | 1 | 2012 | 31 | 0.430 |
Why?
|
| Review Literature as Topic | 1 | 2012 | 71 | 0.430 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2023 | 5437 | 0.420 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 115 | 0.420 |
Why?
|
| Intestinal Mucosa | 5 | 2023 | 1081 | 0.420 |
Why?
|
| Bibliometrics | 1 | 2012 | 71 | 0.410 |
Why?
|
| Risk | 5 | 2020 | 1972 | 0.410 |
Why?
|
| Peer Review, Research | 1 | 2012 | 66 | 0.410 |
Why?
|
| Narcotics | 1 | 2012 | 123 | 0.410 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 276 | 0.400 |
Why?
|
| Diabetes Mellitus | 4 | 2023 | 1054 | 0.390 |
Why?
|
| Vitamin D | 1 | 2013 | 261 | 0.390 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 430 | 0.390 |
Why?
|
| United States | 22 | 2022 | 15433 | 0.380 |
Why?
|
| Adiposity | 1 | 2012 | 237 | 0.380 |
Why?
|
| Risk Factors | 20 | 2023 | 17523 | 0.380 |
Why?
|
| Methadone | 1 | 2012 | 195 | 0.380 |
Why?
|
| Electronic Health Records | 2 | 2019 | 929 | 0.370 |
Why?
|
| Cross-Sectional Studies | 13 | 2022 | 4314 | 0.370 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 622 | 0.370 |
Why?
|
| Humans | 78 | 2023 | 261506 | 0.360 |
Why?
|
| Spouse Abuse | 1 | 2009 | 21 | 0.360 |
Why?
|
| Postmenopause | 5 | 2018 | 378 | 0.350 |
Why?
|
| Gastroenterology | 1 | 2012 | 195 | 0.350 |
Why?
|
| Sex Offenses | 1 | 2010 | 52 | 0.350 |
Why?
|
| Case-Control Studies | 8 | 2021 | 6100 | 0.350 |
Why?
|
| Caffeine | 2 | 2023 | 87 | 0.340 |
Why?
|
| Barrett Esophagus | 4 | 2020 | 569 | 0.340 |
Why?
|
| Feeding Behavior | 2 | 2015 | 808 | 0.330 |
Why?
|
| Bacteria | 4 | 2022 | 611 | 0.320 |
Why?
|
| Incidence | 9 | 2022 | 5673 | 0.320 |
Why?
|
| Male | 40 | 2022 | 123000 | 0.320 |
Why?
|
| Aggression | 1 | 2009 | 252 | 0.310 |
Why?
|
| Aged | 27 | 2020 | 70117 | 0.290 |
Why?
|
| Sex Factors | 5 | 2019 | 2139 | 0.290 |
Why?
|
| Testosterone | 1 | 2011 | 619 | 0.290 |
Why?
|
| Motor Activity | 1 | 2010 | 693 | 0.290 |
Why?
|
| Glutathione Transferase | 1 | 2007 | 359 | 0.280 |
Why?
|
| Coffee | 3 | 2023 | 33 | 0.280 |
Why?
|
| Inflammation | 4 | 2020 | 2522 | 0.280 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 399 | 0.280 |
Why?
|
| Obesity | 4 | 2022 | 2884 | 0.280 |
Why?
|
| Disease Progression | 3 | 2022 | 6682 | 0.270 |
Why?
|
| Substance-Related Disorders | 2 | 2009 | 524 | 0.270 |
Why?
|
| Female | 40 | 2022 | 141928 | 0.260 |
Why?
|
| Esophageal Neoplasms | 5 | 2020 | 3168 | 0.260 |
Why?
|
| Prevalence | 7 | 2020 | 3260 | 0.250 |
Why?
|
| Biomarkers, Tumor | 2 | 2018 | 10331 | 0.250 |
Why?
|
| Persian Gulf Syndrome | 1 | 2023 | 14 | 0.240 |
Why?
|
| Adult | 22 | 2023 | 77950 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 2 | 2018 | 5061 | 0.230 |
Why?
|
| Immunogenetics | 1 | 2023 | 16 | 0.230 |
Why?
|
| Prospective Studies | 12 | 2021 | 12873 | 0.220 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2023 | 60 | 0.220 |
Why?
|
| Trans Fatty Acids | 1 | 2022 | 10 | 0.220 |
Why?
|
| Age Factors | 5 | 2019 | 5377 | 0.220 |
Why?
|
| HIV | 2 | 2021 | 229 | 0.220 |
Why?
|
| RNA, Ribosomal, 16S | 5 | 2023 | 490 | 0.220 |
Why?
|
| Sleep | 2 | 2017 | 413 | 0.210 |
Why?
|
| Alcohol Drinking | 3 | 2020 | 551 | 0.210 |
Why?
|
| Surveys and Questionnaires | 7 | 2023 | 5687 | 0.210 |
Why?
|
| Interleukins | 2 | 2015 | 325 | 0.200 |
Why?
|
| Hyperlipidemias | 1 | 2023 | 235 | 0.200 |
Why?
|
| Gout | 1 | 2021 | 31 | 0.200 |
Why?
|
| Tooth Loss | 1 | 2020 | 5 | 0.190 |
Why?
|
| Risk Assessment | 7 | 2019 | 6869 | 0.190 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 3 | 2018 | 421 | 0.190 |
Why?
|
| Antiviral Agents | 3 | 2017 | 1230 | 0.190 |
Why?
|
| Principal Component Analysis | 2 | 2018 | 218 | 0.190 |
Why?
|
| Periodontal Diseases | 1 | 2020 | 22 | 0.190 |
Why?
|
| Logistic Models | 3 | 2013 | 3441 | 0.190 |
Why?
|
| Calcium-Binding Proteins | 1 | 2023 | 545 | 0.180 |
Why?
|
| Registries | 2 | 2019 | 2170 | 0.180 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 2 | 2017 | 16 | 0.180 |
Why?
|
| Protease Inhibitors | 1 | 2021 | 210 | 0.180 |
Why?
|
| Patient Readmission | 2 | 2015 | 548 | 0.180 |
Why?
|
| Comorbidity | 4 | 2020 | 2352 | 0.180 |
Why?
|
| Osteoarthritis, Knee | 1 | 2022 | 162 | 0.180 |
Why?
|
| Odds Ratio | 3 | 2010 | 2316 | 0.180 |
Why?
|
| Geography | 1 | 2019 | 140 | 0.170 |
Why?
|
| Alphapapillomavirus | 1 | 2021 | 171 | 0.170 |
Why?
|
| Anti-HIV Agents | 1 | 2022 | 350 | 0.170 |
Why?
|
| Health Services Administration | 1 | 2018 | 13 | 0.160 |
Why?
|
| Plasminogen Inactivators | 1 | 2018 | 9 | 0.160 |
Why?
|
| HIV Protease Inhibitors | 1 | 2018 | 72 | 0.160 |
Why?
|
| Alanine Transaminase | 1 | 2018 | 227 | 0.160 |
Why?
|
| Diet, Fat-Restricted | 1 | 2018 | 56 | 0.160 |
Why?
|
| Retrospective Studies | 11 | 2022 | 37905 | 0.150 |
Why?
|
| Adiponectin | 1 | 2018 | 163 | 0.150 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 203 | 0.150 |
Why?
|
| Anus Neoplasms | 1 | 2021 | 411 | 0.150 |
Why?
|
| Receptors, Ghrelin | 1 | 2016 | 35 | 0.140 |
Why?
|
| Databases, Factual | 3 | 2020 | 2218 | 0.140 |
Why?
|
| Mexican Americans | 1 | 2018 | 322 | 0.140 |
Why?
|
| Ghrelin | 1 | 2016 | 79 | 0.140 |
Why?
|
| Leptin | 1 | 2018 | 295 | 0.140 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 4971 | 0.140 |
Why?
|
| Nutritional Sciences | 1 | 2016 | 68 | 0.140 |
Why?
|
| Cohort Studies | 8 | 2022 | 9244 | 0.140 |
Why?
|
| Hypertension | 2 | 2023 | 1503 | 0.140 |
Why?
|
| Psychiatric Rehabilitation | 1 | 2015 | 8 | 0.130 |
Why?
|
| Alcohol Abstinence | 1 | 2015 | 17 | 0.130 |
Why?
|
| Arthroplasty, Replacement | 1 | 2015 | 27 | 0.130 |
Why?
|
| Activities of Daily Living | 2 | 2016 | 552 | 0.130 |
Why?
|
| Bias | 2 | 2013 | 205 | 0.130 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2020 | 297 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2023 | 1823 | 0.130 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 6009 | 0.120 |
Why?
|
| Mortality | 1 | 2016 | 343 | 0.120 |
Why?
|
| Hospitals, Veterans | 2 | 2018 | 397 | 0.120 |
Why?
|
| ROC Curve | 1 | 2017 | 1183 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 1362 | 0.120 |
Why?
|
| Microbiota | 1 | 2020 | 547 | 0.120 |
Why?
|
| Young Adult | 4 | 2019 | 21445 | 0.120 |
Why?
|
| Health Education | 1 | 2016 | 309 | 0.120 |
Why?
|
| Severity of Illness Index | 6 | 2018 | 4320 | 0.120 |
Why?
|
| Adenocarcinoma | 4 | 2020 | 7789 | 0.120 |
Why?
|
| Elective Surgical Procedures | 1 | 2015 | 250 | 0.120 |
Why?
|
| Diet Records | 1 | 2013 | 77 | 0.110 |
Why?
|
| Colorectal Surgery | 1 | 2013 | 32 | 0.110 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 29902 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 2015 | 305 | 0.110 |
Why?
|
| Fructose | 1 | 2013 | 72 | 0.110 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2012 | 40 | 0.110 |
Why?
|
| Hepatitis | 1 | 2013 | 93 | 0.110 |
Why?
|
| Behavior Therapy | 1 | 2015 | 298 | 0.110 |
Why?
|
| Dietary Carbohydrates | 1 | 2013 | 134 | 0.110 |
Why?
|
| Alcoholism | 1 | 2015 | 285 | 0.110 |
Why?
|
| Disease Management | 1 | 2018 | 1052 | 0.110 |
Why?
|
| Chemoradiotherapy | 1 | 2021 | 1946 | 0.110 |
Why?
|
| Primary Health Care | 1 | 2018 | 787 | 0.100 |
Why?
|
| Optical Imaging | 1 | 2013 | 157 | 0.100 |
Why?
|
| Neurofibrillary Tangles | 1 | 1991 | 24 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 4298 | 0.100 |
Why?
|
| Endosonography | 1 | 2014 | 536 | 0.100 |
Why?
|
| Data Collection | 2 | 2010 | 620 | 0.090 |
Why?
|
| Endemic Diseases | 1 | 2010 | 67 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 598 | 0.090 |
Why?
|
| Vietnam Conflict | 1 | 2009 | 9 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 2195 | 0.090 |
Why?
|
| Vietnam | 1 | 2009 | 56 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2018 | 2203 | 0.090 |
Why?
|
| Endoscopy | 1 | 2013 | 479 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 4892 | 0.090 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2009 | 106 | 0.090 |
Why?
|
| Afghan Campaign 2001- | 1 | 2009 | 111 | 0.090 |
Why?
|
| Viral Load | 1 | 2011 | 493 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 4821 | 0.090 |
Why?
|
| Hepatitis B | 2 | 2010 | 258 | 0.090 |
Why?
|
| Mass Screening | 1 | 2018 | 1509 | 0.090 |
Why?
|
| Neoplasms | 4 | 2021 | 15193 | 0.090 |
Why?
|
| Proportional Hazards Models | 4 | 2019 | 4988 | 0.080 |
Why?
|
| Colorectal Neoplasms | 2 | 2016 | 3578 | 0.080 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 1249 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2015 | 5539 | 0.080 |
Why?
|
| Papillomaviridae | 2 | 2022 | 624 | 0.080 |
Why?
|
| Dyspepsia | 1 | 2008 | 103 | 0.080 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2007 | 69 | 0.080 |
Why?
|
| Feces | 2 | 2021 | 770 | 0.080 |
Why?
|
| Unsafe Sex | 1 | 2007 | 21 | 0.070 |
Why?
|
| Military Personnel | 1 | 2009 | 225 | 0.070 |
Why?
|
| Biomarkers | 3 | 2018 | 5047 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2013 | 1171 | 0.070 |
Why?
|
| Time Factors | 3 | 2017 | 12926 | 0.070 |
Why?
|
| Stomach Neoplasms | 1 | 2019 | 2278 | 0.070 |
Why?
|
| Methamphetamine | 1 | 2007 | 61 | 0.070 |
Why?
|
| Quality of Life | 3 | 2009 | 4532 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2007 | 756 | 0.070 |
Why?
|
| Depressive Disorder | 1 | 2010 | 557 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2007 | 249 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2018 | 4549 | 0.070 |
Why?
|
| Medical Records | 1 | 2007 | 415 | 0.070 |
Why?
|
| Coinfection | 2 | 2017 | 189 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2007 | 614 | 0.070 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 225 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 2594 | 0.060 |
Why?
|
| Adolescent Behavior | 1 | 2007 | 230 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2007 | 323 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 1323 | 0.060 |
Why?
|
| Gulf War | 1 | 2023 | 8 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 435 | 0.060 |
Why?
|
| Genotype | 2 | 2013 | 4109 | 0.060 |
Why?
|
| Needlestick Injuries | 1 | 2003 | 7 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2007 | 901 | 0.060 |
Why?
|
| Protective Devices | 1 | 2003 | 21 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 1991 | 855 | 0.060 |
Why?
|
| Circadian Rhythm | 2 | 2017 | 330 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2008 | 589 | 0.060 |
Why?
|
| Texas | 2 | 2012 | 6311 | 0.060 |
Why?
|
| Interferons | 2 | 2015 | 291 | 0.050 |
Why?
|
| Nurses | 1 | 2003 | 80 | 0.050 |
Why?
|
| Aging | 1 | 1991 | 1582 | 0.050 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2022 | 71 | 0.050 |
Why?
|
| Adenosine Deaminase | 1 | 2022 | 94 | 0.050 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2022 | 61 | 0.050 |
Why?
|
| Occupational Diseases | 1 | 2003 | 130 | 0.050 |
Why?
|
| Cardiomyopathies | 1 | 2008 | 610 | 0.050 |
Why?
|
| Verrucomicrobia | 1 | 2021 | 26 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2019 | 1546 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2008 | 1000 | 0.050 |
Why?
|
| Catheterization, Peripheral | 1 | 2003 | 158 | 0.050 |
Why?
|
| Knee Joint | 1 | 2022 | 161 | 0.050 |
Why?
|
| Oral Health | 1 | 2020 | 18 | 0.050 |
Why?
|
| Bacterial Load | 1 | 2020 | 46 | 0.050 |
Why?
|
| Intraocular Pressure | 1 | 2021 | 146 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2022 | 241 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2022 | 339 | 0.050 |
Why?
|
| Research Design | 1 | 2008 | 1544 | 0.050 |
Why?
|
| Sample Size | 2 | 2013 | 202 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 849 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2021 | 32848 | 0.040 |
Why?
|
| Food Analysis | 1 | 2019 | 28 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2022 | 448 | 0.040 |
Why?
|
| Weight Gain | 1 | 2022 | 464 | 0.040 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2018 | 44 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2022 | 650 | 0.040 |
Why?
|
| International Classification of Diseases | 1 | 2019 | 83 | 0.040 |
Why?
|
| Heart Failure | 2 | 2016 | 2516 | 0.040 |
Why?
|
| Smoking | 2 | 2019 | 2440 | 0.040 |
Why?
|
| Edible Grain | 1 | 2018 | 54 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2019 | 298 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 130 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2013 | 5542 | 0.040 |
Why?
|
| Protective Factors | 1 | 2018 | 106 | 0.040 |
Why?
|
| Platelet Count | 1 | 2018 | 490 | 0.040 |
Why?
|
| Prognosis | 1 | 2015 | 21713 | 0.040 |
Why?
|
| Body Weight | 1 | 2022 | 1293 | 0.040 |
Why?
|
| Radiography | 1 | 2022 | 1904 | 0.040 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1998 | 82 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 558 | 0.040 |
Why?
|
| Hepatitis B, Chronic | 1 | 2018 | 137 | 0.040 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 164 | 0.040 |
Why?
|
| SEER Program | 1 | 2020 | 1000 | 0.040 |
Why?
|
| Life Style | 1 | 2020 | 612 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2003 | 918 | 0.040 |
Why?
|
| Women's Health | 1 | 2017 | 205 | 0.030 |
Why?
|
| Fruit | 1 | 2018 | 294 | 0.030 |
Why?
|
| Paris | 1 | 2015 | 10 | 0.030 |
Why?
|
| Vegetables | 1 | 2018 | 325 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2015 | 173 | 0.030 |
Why?
|
| Survival Rate | 2 | 2020 | 12221 | 0.030 |
Why?
|
| Phenotype | 2 | 2022 | 6295 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 756 | 0.030 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 170 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2016 | 337 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 7702 | 0.030 |
Why?
|
| Contraindications | 1 | 2013 | 150 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 752 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2018 | 1021 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 590 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 1271 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 2483 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 3443 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2013 | 205 | 0.030 |
Why?
|
| Adolescent | 2 | 2010 | 31252 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2018 | 1863 | 0.030 |
Why?
|
| Amyloid | 1 | 1991 | 97 | 0.020 |
Why?
|
| Asia, Southeastern | 1 | 2010 | 23 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 1258 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2013 | 205 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 1163 | 0.020 |
Why?
|
| Africa South of the Sahara | 1 | 2010 | 101 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 2019 | 1295 | 0.020 |
Why?
|
| Overweight | 1 | 2012 | 484 | 0.020 |
Why?
|
| Length of Stay | 1 | 2015 | 1900 | 0.020 |
Why?
|
| Autonomic Agents | 1 | 2008 | 3 | 0.020 |
Why?
|
| Selenoproteins | 1 | 2008 | 17 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 14889 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 1011 | 0.020 |
Why?
|
| Ubiquinone | 1 | 2008 | 37 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 2008 | 425 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2008 | 162 | 0.020 |
Why?
|
| Brain Mapping | 1 | 1991 | 644 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 1021 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 1099 | 0.020 |
Why?
|
| Surgery, Plastic | 1 | 1993 | 344 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2008 | 159 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2012 | 731 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2008 | 252 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2008 | 226 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2008 | 248 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2007 | 179 | 0.020 |
Why?
|
| Patient Selection | 1 | 2013 | 2055 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 2359 | 0.020 |
Why?
|
| Hippocampus | 1 | 1991 | 915 | 0.020 |
Why?
|
| Global Health | 1 | 2010 | 657 | 0.020 |
Why?
|
| Antioxidants | 1 | 2008 | 507 | 0.020 |
Why?
|
| Animals | 2 | 2022 | 59536 | 0.020 |
Why?
|
| Stroke | 1 | 2013 | 1144 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 461 | 0.020 |
Why?
|
| Pedigree | 1 | 2008 | 1890 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 891 | 0.010 |
Why?
|
| Hospitals, Urban | 1 | 2003 | 87 | 0.010 |
Why?
|
| Time | 1 | 2003 | 178 | 0.010 |
Why?
|
| Inservice Training | 1 | 2003 | 78 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2003 | 120 | 0.010 |
Why?
|
| Organizational Culture | 1 | 2003 | 106 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 7551 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2007 | 554 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2007 | 661 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1993 | 1375 | 0.010 |
Why?
|
| Myocardium | 1 | 2008 | 1313 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 1547 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1991 | 7548 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 13658 | 0.010 |
Why?
|
| Cytokines | 1 | 2008 | 2809 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 1998 | 224 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 3719 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1998 | 543 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2003 | 1209 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1998 | 2803 | 0.010 |
Why?
|